A suitable drug structure for interaction with SARS-CoV-2 main protease between boceprevir, masitinib and

Mehdi Yoosefian1,2, Razieh Dashti2, Mohamad Mahani1

  • 1Department of Chemistry, Graduate University of Advanced Technology, Kerman, Iran.

Arabian Journal of Chemistry
|June 16, 2023
PubMed